The Wayne, Penn.-based company’s device integrates with the AsthmaMD smartphone app, which digitally logs peak flow meter readings, symptoms and medication use. The app also helps patients share the collected data with their physicians using the cloud-based MyAsthmaMD Physician Portal.
“Teleflex is committed to connecting clinicians and patients with technology that improves patient outcomes,” president of Teleflex’s respiratory division, James Ferguson said in prepared remarks. “Asthma is the 3rd-leading cause of hospitalization in children and Teleflex is proud to now offer the AsthmaMD Peak Flow Meter to help these and other asthma patients.”
Teleflex paid 30.2¢ apiece for the roughly 28.5 million shares in Pyng, which makes intraosseous infusion technology, pelvic stabilization & emergency tourniquet devices.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.